LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED
LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED is a Pre-seed, Seed, Series A, Series B, Series C+ and buyout fund in the US, global and Asia investing in Healthcare, biopharma, drug-discovery, surgical-robotics, medical-aesthetics, pharma, medical-devices and diagnostics.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+, buyout
- Sectors
- Healthcare, biopharma, drug-discovery, surgical-robotics, medical-aesthetics, pharma, medical-devices, diagnostics
- Invests in
- US-wide, global, Asia
- Actively investing
- Yes
- Founded
- 2015
- Assets under management
- $2B
Check size not disclosed
Thesis
LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED, founded in 2015, is a global healthcare investment firm with a transpacific strategy, operating from five offices in Menlo Park, Seoul, Shanghai, Tokyo, and Singapore. Their investment thesis focuses on critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services, targeting companies from pre-seed to Series C, particularly those with established products seeking growth capital. The firm employs a strategy of building meaningful positions in high-growth leaders through geographic revenue expansion and bolt-on acquisitions, aiming to drive significant revenue growth by leveraging mature global markets, Asian cost efficiencies, and U.S. innovation. LYFE Capital also incorporates ESG principles, promoting virtual meetings and seeking to reduce environmental impact. As of recent reports, the firm manages approximately $2 billion in AUM, with its latest fund, Fund IV, closing in 2022 with $935 million. Specific investment sizes per deal are not publicly disclosed.
Common questions
Does LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED invest at the Pre-seed stage?
Yes. LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED lists Pre-seed, Seed, Series A, Series B, Series C+ and buyout among the stages it invests in.
Where does LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED invest?
LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED invests in the US, global and Asia.